Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-26-007819
Filing Date
2026-08-07
Accepted
2026-08-07 16:39:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3315
  Complete submission text file 0001950047-26-007819.txt   4898
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37722 | Film No.: 261254946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATLAS VENTURE 300 TECHNOLOGY SQ, 8TH FLOOR CAMBRIDGE MA 02139
Business Address
Albers Jeffrey W. (Reporting) CIK: 0001638474 (see all company filings)

Type: 144